AKR.L : Summary for AKERS BIOSCIENCES, INC. COM SHS - Yahoo Finance

U.S. Markets close in 5 hrs 51 mins

Akers Biosciences, Inc. (AKR.L)

LSE - LSE Delayed Price. Currency in GBp
Add to watchlist
120.00-7.50 (-5.88%)
As of 2:45PM GMT. Market open.
People also watch
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
Previous Close127.50
Bid120.00 x 120000
Ask135.00 x 120000
Day's Range120.00 - 120.00
52 Week Range80.00 - 255.00
Avg. Volume2,620
Market Cap6.54M
PE Ratio (TTM)-111.11
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Marketwired4 days ago

    Akers Biosciences Announces Closing of Public Offering

    Akers Biosciences, Inc. , , a developer of rapid health information technologies, today announces the closing of its previously announced underwritten public offering of 1,667,000 shares of common stock ...

  • American City Business Journals6 days ago

    South Jersey maker of rapid screening tests plans $2M stock sale

    A South Jersey company that makes rapid screening and diagnostic testing products is looking to raise $2 million in a public stock sale. Akers Biosciences Inc. of Thorofare, New Jersey, is selling just under 1.7 million shares of common stock and five-year warrants to purchase up to 833,500 shares of common stock at a combined public offering price of $1.20 per share and half-warrant.

  • 24/7 Wall St.7 days ago

    Tuesday’s Top Biopharma Movers

    Considering the new Trump administration, there is an increasingly positive sentiment in the health care sector. In the past year, the health care sector was in trouble under fire from congressional hearings ...